glp-1 ed receptor agonist use may be associated with a modest increase in erectile dysfunction (ED) risk in men with type 2 diabetes, a target trial emulation suggested. affects nearly 50% of 1 medications or looking to feel their best every day. GLP-1 Agonists: A Comprehensive Overview

Eli Lillys patents on those two brand-name drugs are valid in the United States until 2036, but they are expiring in other countries

The number of metabolic and bariatric surgery procedures in the United States dropped below 200,000 in 2024 for the first time since 2020, a more than 20% decline from the prior year, according to new research presented today at the annual scientific meeting of the American Society for Metabolic and Bariatric Surgery (#ASMBS2026)

SeekPeptides members get access to detailed stacking protocols and guidance for combining multiple peptides safely

Exploring the Role of GLP-1 Receptor Agonists in Alzheimers Disease: A Review of Preclinical and Clinical Evidence